ADC Bio secures funding to further manufacturing plans
The company announced an investment of £2.5m to design its downstream formulation and filling operations.
Archives for November 16, 2018
Regulator recommends Samsung BioLogics axe CEO over accounting controversy
The SFC ruled that Samsung BioLogics had intentionally violated accounting rules to inflate the price of its IPO.
Pfizer biosimilar undercuts J&J Procrit pricing by 57%
Pfizer has launched the first biosimilar to J&J’s Procrit and Amgen’s Epogen in the US at a ‘significant discount’ to competitors’ wholesale acquisition costs.